Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsParabolicdrugs

    Jump to

    • Eyeing Rs 150cr from dosage biz in 3-5 yrs: Parabolic Drugs

      Parabolic Drugs has entered the dosage space with an aim to make Rs 150 crore by way of sales within 3-5 years, said director Vineet Gupta.

    • Parabolic Drugs set to launch 17 products in 3 yrs

      Vineet Gupta, director of Parabolic Drugs spoke to CNBC-TV18 about the latest with is company and the way ahead.

    • Parabolic Drugs in talks with cos for bulk supply deals

      There are reports stating that Parabolic Drugs is in talks with Japanese firms for bulk supply deals. In an interview to CNBC-TV18, Vineet Gupta, director of Parabolic Drugs confirmed the same.

    • With 3 new expansions, FY12 to see 25% growth: Parabolic

      Parabolic Drugs recently announced its results for the fourth quarter and for the financial year that ended March 31, 2011. Vineet Gupta, director of the company, says he is hopeful that new expansions “will help contribute to further margin expansion.”

    • Parabolic eyes Rs 20cr sales via new alliance next year

      In an interview with CNBC-TV18’s Latha Venkatesh and Reema Tendulkar, Vineet Gupta, Director of Parabolic Drugs, spoke on their pact with a local company on manufacturing nutraceutical bulk drugs.

    • Parabolic Drugs eyes Rs 900cr sales next year

      In an interview CNBC-TV18, Vineet Gupta, Director, Parabolic Drugs, speaks about the results and gives his outlook going forward.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347